MacroGenics
MGNX
#8501
Rank
NZ$0.37 B
Marketcap
NZ$5.91
Share price
0.58%
Change (1 day)
172.84%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.37 Billion

As of April 2026 MacroGenics has a market cap of NZ$0.37 Billion. This makes MacroGenics the world's 8501th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.37 B113.47%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Apr 13th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.37 Billion
by Nasdaq info icon info icon
NZ$0.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$261.01 B 69,432.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.395 T 371,701.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$320.05 B 85,158.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$295.11 B 78,515.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$501.18 B 133,408.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$200.95 B 53,432.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.55 B 314.26%๐Ÿ‡บ๐Ÿ‡ธ USA